NAGIOS: RODERIC FUNCIONANDO

Prognostic Impact of Phosphorylated HER-2 in HER-2+ Primary Breast Cancer

Repositori DSpace/Manakin

dc.contributor.author	Hayashi, Naoki	es_ES
dc.contributor.author	Iwamoto, Takayuki	es_ES
dc.contributor.author	González-Angulo, Ana María	es_ES
dc.contributor.author	Ferrer-Lozano, Jaime	es_ES
dc.contributor.author	Lluch Hernández, Ana	es_ES
dc.contributor.author	Niikura, Naoki	es_ES
dc.contributor.author	Bartholomeusz, Chandra	es_ES
dc.contributor.author	Nakamura, Seigo	es_ES
dc.contributor.author	Hortobagyi, Gabriel N.	es_ES
dc.contributor.author	Ueno, Naoto T.	es_ES
dc.date.accessioned	2015-06-22T09:50:06Z
dc.date.available	2015-06-22T09:50:06Z
dc.date.issued	2011	es_ES
dc.identifier.citation	The Oncologist Vol. 16 Issue 7: pp. 956-965	es_ES
dc.identifier.uri	http://hdl.handle.net/10550/44664
dc.description.abstract	The prognostic value of the expression level of tyrosine 1248–phosphorylated human epidermal growth factor receptor (HER)-2 in patients with HER-2+ primary breast cancer is examined.	es_ES
dc.subject	Breast cancer	es_ES
dc.subject	HER-2	es_ES
dc.subject	Reverse-phase protein array	es_ES
dc.subject	Metastases	es_ES
dc.subject	Phosphorylation	es_ES
dc.title	Prognostic Impact of Phosphorylated HER-2 in HER-2+ Primary Breast Cancer	es_ES
dc.type	journal article	es_ES
dc.identifier.doi	10.1634/theoncologist.2010-0409	es_ES
dc.identifier.idgrec	070444	es_ES